Literature DB >> 26514543

Myopathy associated with neuromyelitis optica spectrum disorders.

Dian He1, Ya Li1, Qingqing Dai1, Yifan Zhang1, Zhu Xu1, Yuan Li1, Gang Cai1, Lan Chu1.   

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) were generally thought to affect only central nervous system and spare peripheral aquaporin-4 (AQP4)-expressing organs. In recent years, however, increasing evidence has shown that skeletal muscle is involved in NMOSD. We provided a comprehensive review of the relevant literature and summarized the clinical and pathological characteristics of myopathy associated with NMOSD. NMOSD-associated myopathy seems to be characterized by mild muscle symptoms with prominent hyperCKemia and minimal changes on conventional pathological staining. Loss of AQP4 and deposition of IgG and activated complement products on sarcolemma of type II fibers are diagnostic features on immunohistochemical examinations. Creatine kinase leakage as a result of AQP4-IgG-induced, complement-mediated sarcolemmal injury may be a potential mechanism for hyperCKemia. Myopathy should be considered a component of NMOSD unified by AQP4-IgG seropositivity.

Entities:  

Keywords:  AQP4-IgG; hyperCKemia; longitudinally extensive transverse myelitis; myopathy; neuromyelitis optica spectrum disorders; optic neuritis

Mesh:

Year:  2015        PMID: 26514543     DOI: 10.3109/00207454.2015.1113175

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  6 in total

Review 1.  Pattern Recognition of the Multiple Sclerosis Syndrome.

Authors:  Rana K Zabad; Renee Stewart; Kathleen M Healey
Journal:  Brain Sci       Date:  2017-10-24

Review 2.  Neuromyelitis Optica: Deciphering a Complex Immune-Mediated Astrocytopathy.

Authors:  Jeffrey L Bennett; Gregory P Owens
Journal:  J Neuroophthalmol       Date:  2017-09       Impact factor: 3.042

3.  Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies.

Authors:  Patrick Murtagh; Amy Coman; Kirk Stephenson; Maria Gaughan; David Ryan; Graeme McNeill; Christopher McGuigan; Lorraine Cassidy
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

4.  Muscle damage in patients with neuromyelitis optica spectrum disorder.

Authors:  Hong-Xi Chen; Qin Zhang; Zhi-Yun Lian; Ju Liu; Zi-Yan Shi; Xiao-Hui Miao; Hui-Ru Feng; Qin Du; Jing-Lu Xie; Shao-Li Yao; Hong-Yu Zhou
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-09-13

5.  Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis optica.

Authors:  Stefania Rosito; Grazia Paola Nicchia; Claudia Palazzo; Anna Lia; Cinzia Buccoliero; Francesco Pisani; Maria Svelto; Maria Trojano; Antonio Frigeri
Journal:  J Cell Mol Med       Date:  2017-10-20       Impact factor: 5.310

Review 6.  Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.

Authors:  Jinming Han; Meng-Ge Yang; Jie Zhu; Tao Jin
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-20       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.